Friday, July 10, 2026

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 15 of 39
  1. Forsteo

    Hospital Authority, Hong Kong

    Spine Deformity

    approved small molecule active

    1 trial
  2. Fosinopril

    The First People's Hospital of Lianyungang

    Chronic Kidney Disease

    approved small molecule active

    1 trial
  3. Freezor® Cardiac Cryoablation Catheter CryoConsole System

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Atrioventricular Nodal Reentry

    approved other completed

    1 trial
  4. Fremanezumab

    Teva Pharma GmbH

    Migraine

    approved small molecule active

    9 trials
  5. Fremanezumab Prefilled Syringe [Ajovy]

    Teva Pharma GmbH

    Migraine Disorders

    approved small molecule terminated

    1 trial
  6. Fruquintinib

    Takeda

    Colorectal Cancer

    approved small molecule active

    1 trial
  7. FuKe Qianjin Capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Endometritis

    approved small molecule active

    1 trial
  8. GAVRETO ®(pralsetinib) capsules

    RIGEL PHARMACEUTICALS INC

    Patients with advanced or metastatic solid tumors

    approved small molecule active

    1 trial
  9. GEICAM/2023-09

    Ningbo Cancer Hospital

    Early Breast Cancer

    approved small molecule active

    1 trial
  10. GR-2021-12373041

    Verona Pharma Ireland Limited

    patients with secondary progressive MS

    approved small molecule active

    1 trial
  11. GTM-103

    GT Biopharma

    Glioblastoma

    approved other active

    1 trial
  12. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Lennox-Gastaut Syndrome

    approved small molecule terminated

    1 trial
  13. Gabapentin

    United Therapeutics Europe Ltd

    Peripheral Nerve Disorder Associated With Repair of Hernia

    approved small molecule active

    1 trial
  14. GadoCrohn

    The George Institute

    Perianal fistula associated with Crohn's disease

    approved small molecule active

    1 trial
  15. Gadoterate meglumine

    Guerbet

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial
  16. Gadoxetate disodium

    Guerbet

    Motor Function

    approved small molecule active

    1 trial
  17. Ganciclovir

    Hoffmann-La Roche

    Cytomegalovirus Infections

    approved small molecule completed

    1 trial
  18. Gardasil 9 suspension for Evaluation of the reduction of…

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial
  19. Glatiramer Acetate

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    approved small molecule terminated

    5 trials
  20. Glucagon-like peptide-1 receptor agonist:Semaglutide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    approved small molecule active

    1 trial
  21. Glycopyrronium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Nausea and Vomiting

    approved small molecule active

    1 trial
  22. Glycopyrronium in Combination With Tropisetron

    The First People's Hospital of Lianyungang

    Postoperative Nausea and Vomiting

    approved small molecule completed

    1 trial
  23. Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    approved small molecule terminated

    1 trial
  24. Group 1 Standard of Care

    Pacira Ireland Limited

    Retraction of Colostomy

    approved small molecule completed

    1 trial
  25. Group A (the standard 2HRZE/4HR regimen)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Tuberculosis TB in Sputum: (+) Microscopy

    approved small molecule completed

    1 trial
  26. Group C : Saline + propofol group

    Hospital Authority, Hong Kong

    Urologic Surgery

    approved small molecule completed

    1 trial
  27. Guanfacine hydrochloride (TAK-503)

    Takeda

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial
  28. Guilingji Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oligospermia

    approved small molecule active

    1 trial
  29. Guli capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    approved small molecule active

    1 trial
  30. Guselkumab

    Janssen Cilag International NV

    Arthritis, Psoriatic

    approved small molecule active

    3 trials
  31. H1N1 influenza A Vaccine (PANFLU.1)

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial
  32. HAC2018-001

    H.A.C. Pharma

    Neurogenic Orthostatic Hypotension

    approved small molecule active

    1 trial
  33. HCB.2021.1309

    The George Institute

    Coronary artery chronic total occlusion

    approved small molecule active

    1 trial
  34. HCV-001

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B Vaccines

    approved mab completed

    1 trial
  35. HEBRO-001

    The George Institute

    Hypertension

    approved small molecule active

    1 trial
  36. HIPRA-HH-17

    Hipra Human Health S.L.

    COVID-19

    approved small molecule active

    1 trial
  37. HTX-011

    Heron Therapeutics

    Postoperative Pain

    approved small molecule completed

    8 trials
  38. HTX-011

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    6 trials
  39. HUMAN SERUM ALBUMIN, SODIUM CHLORIDE

    The George Institute

    descompensated hepatic cirrosis

    approved small molecule active

    1 trial
  40. HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.

    The George Institute

    Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).

    approved small molecule active

    1 trial
  41. HYQVIA

    Takeda

    Primary Immunodeficiency Diseases (PID)

    approved mab completed

    2 trials
  42. Haloperidol

    United Therapeutics Europe Ltd

    Migraine Headaches

    approved small molecule terminated

    1 trial
  43. Harvoni (Fixed dose combination ledipasvir/sofosbuvir)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial
  44. Healive+Healive

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial
  45. Healive® Lot 1

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial
  46. Heliox inspirate

    United Therapeutics Europe Ltd

    Work of Breathing

    approved small molecule active

    1 trial
  47. Hemlibra 150 mg/mL solution for injection

    Hoffmann-La Roche

    Severe or Moderate Hemophilia A

    approved small molecule active

    1 trial
  48. Hemodialysis with Polymethylmethacrylate Artificial Kidney

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Uremia

    approved other completed

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.